Global Acute Myeloid Leukemia (AML) Therapeutic Market Research Report 2016

November 2016 | 110 pages | ID: GEECBF20A3EEN
QYResearch

Abstracts

Notes:

Production, means the output of Acute Myeloid Leukemia (AML) Therapeutic

Revenue, means the sales value of Acute Myeloid Leukemia (AML) Therapeutic

This report studies Acute Myeloid Leukemia (AML) Therapeutic in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Ambit Biosciences Inc. (US)
• Aprea AB (Sweden)
• Astellas Pharma Inc. (Japan)
• Astex Pharmaceuticals, Inc. (US)
• Bio-Path Holdings, Inc. (US)
• BioSante Pharmaceuticals, Inc. (US)
• Celator Pharmaceuticals, Inc. (US)
• Celgene Corp. (US)
• Clavis Pharma ASA (Norway)
• Cyclacel Pharmaceuticals, Inc. (US)
• EpiCept Corp. (US)
• Genzyme Corporation (US)
• Lorus Therapeutics, Inc. (Canada)
• Novartis AG (Switzerland)
• Onconova Therapeutics, Inc. (US)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Acute Myeloid Leukemia (AML) Therapeutic in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Acute Myeloid Leukemia (AML) Therapeutic in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Acute Myeloid Leukemia (AML) Therapeutic Market Research Report 2016

1 ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC MARKET OVERVIEW

1.1 Product Overview and Scope of Acute Myeloid Leukemia (AML) Therapeutic
1.2 Acute Myeloid Leukemia (AML) Therapeutic Segment by Type
  1.2.1 Global Production Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Acute Myeloid Leukemia (AML) Therapeutic Segment by Application
  1.3.1 Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Acute Myeloid Leukemia (AML) Therapeutic Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Acute Myeloid Leukemia (AML) Therapeutic (2011-2021)

2 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC MARKET COMPETITION BY MANUFACTURERS

2.1 Global Acute Myeloid Leukemia (AML) Therapeutic Production and Share by Manufacturers (2015 and 2016)
2.2 Global Acute Myeloid Leukemia (AML) Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Acute Myeloid Leukemia (AML) Therapeutic Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Acute Myeloid Leukemia (AML) Therapeutic Manufacturing Base Distribution, Sales Area and Product Type
2.5 Acute Myeloid Leukemia (AML) Therapeutic Market Competitive Situation and Trends
  2.5.1 Acute Myeloid Leukemia (AML) Therapeutic Market Concentration Rate
  2.5.2 Acute Myeloid Leukemia (AML) Therapeutic Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Acute Myeloid Leukemia (AML) Therapeutic Production and Market Share by Region (2011-2016)
3.2 Global Acute Myeloid Leukemia (AML) Therapeutic Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Acute Myeloid Leukemia (AML) Therapeutic Consumption by Regions (2011-2016)
4.2 North America Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Acute Myeloid Leukemia (AML) Therapeutic Production and Market Share by Type (2011-2016)
5.2 Global Acute Myeloid Leukemia (AML) Therapeutic Revenue and Market Share by Type (2011-2016)
5.3 Global Acute Myeloid Leukemia (AML) Therapeutic Price by Type (2011-2016)
5.4 Global Acute Myeloid Leukemia (AML) Therapeutic Production Growth by Type (2011-2016)

6 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC MARKET ANALYSIS BY APPLICATION

6.1 Global Acute Myeloid Leukemia (AML) Therapeutic Consumption and Market Share by Application (2011-2016)
6.2 Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC MANUFACTURERS PROFILES/ANALYSIS

7.1 Ambit Biosciences Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Ambit Biosciences Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Aprea AB (Sweden)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Aprea AB (Sweden) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Astellas Pharma Inc. (Japan)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Astellas Pharma Inc. (Japan) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Astex Pharmaceuticals, Inc. (US)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Astex Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bio-Path Holdings, Inc. (US)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bio-Path Holdings, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 BioSante Pharmaceuticals, Inc. (US)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 BioSante Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Celator Pharmaceuticals, Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Celator Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Celgene Corp. (US)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Celgene Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Clavis Pharma ASA (Norway)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Clavis Pharma ASA (Norway) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Cyclacel Pharmaceuticals, Inc. (US)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Cyclacel Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 EpiCept Corp. (US)
7.12 Genzyme Corporation (US)
7.13 Lorus Therapeutics, Inc. (Canada)
7.14 Novartis AG (Switzerland)
7.15 Onconova Therapeutics, Inc. (US)

8 ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC MANUFACTURING COST ANALYSIS

8.1 Acute Myeloid Leukemia (AML) Therapeutic Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Acute Myeloid Leukemia (AML) Therapeutic

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Acute Myeloid Leukemia (AML) Therapeutic Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Acute Myeloid Leukemia (AML) Therapeutic Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ACUTE MYELOID LEUKEMIA (AML) THERAPEUTIC MARKET FORECAST (2016-2021)

12.1 Global Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue Forecast (2016-2021)
12.2 Global Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Acute Myeloid Leukemia (AML) Therapeutic Production Forecast by Type (2016-2021)
12.4 Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Forecast by Application (2016-2021)
12.5 Acute Myeloid Leukemia (AML) Therapeutic Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Acute Myeloid Leukemia (AML) Therapeutic
Figure Global Production Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production of Key Manufacturers (2015 and 2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production Share by Manufacturers (2015 and 2016)
Figure 2015 Acute Myeloid Leukemia (AML) Therapeutic Production Share by Manufacturers
Figure 2016 Acute Myeloid Leukemia (AML) Therapeutic Production Share by Manufacturers
Table Global Acute Myeloid Leukemia (AML) Therapeutic Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Manufacturers
Table 2016 Global Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Manufacturers
Table Global Market Acute Myeloid Leukemia (AML) Therapeutic Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Acute Myeloid Leukemia (AML) Therapeutic Average Price of Key Manufacturers in 2015
Table Manufacturers Acute Myeloid Leukemia (AML) Therapeutic Manufacturing Base Distribution and Sales Area
Table Manufacturers Acute Myeloid Leukemia (AML) Therapeutic Product Type
Figure Acute Myeloid Leukemia (AML) Therapeutic Market Share of Top 3 Manufacturers
Figure Acute Myeloid Leukemia (AML) Therapeutic Market Share of Top 5 Manufacturers
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production by Regions (2011-2016)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Production and Market Share by Regions (2011-2016)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Production Market Share by Regions (2011-2016)
Figure 2015 Global Acute Myeloid Leukemia (AML) Therapeutic Production Market Share by Regions
Table Global Acute Myeloid Leukemia (AML) Therapeutic Revenue by Regions (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Revenue Market Share by Regions (2011-2016)
Table 2015 Global Acute Myeloid Leukemia (AML) Therapeutic Revenue Market Share by Regions
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table China Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table India Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Market by Regions (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Regions (2011-2016)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Regions
Table North America Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Import & Export (2011-2016)
Table China Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Japan Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Import & Export (2011-2016)
Table India Acute Myeloid Leukemia (AML) Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production by Type (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production Share by Type (2011-2016)
Figure Production Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type (2011-2016)
Figure 2015 Production Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type
Table Global Acute Myeloid Leukemia (AML) Therapeutic Revenue by Type (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Acute Myeloid Leukemia (AML) Therapeutic by Type (2011-2016)
Figure 2015 Revenue Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type
Table Global Acute Myeloid Leukemia (AML) Therapeutic Price by Type (2011-2016)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Production Growth by Type (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption by Application (2011-2016)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Application (2011-2016)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Market Share by Application in 2015
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Growth Rate by Application (2011-2016)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Growth Rate by Application (2011-2016)
Table Ambit Biosciences Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ambit Biosciences Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ambit Biosciences Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Aprea AB (Sweden) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aprea AB (Sweden) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Aprea AB (Sweden) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Astellas Pharma Inc. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Inc. (Japan) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Inc. (Japan) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Astex Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astex Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astex Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Bio-Path Holdings, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bio-Path Holdings, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bio-Path Holdings, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table BioSante Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioSante Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure BioSante Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Celator Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celator Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celator Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Celgene Corp. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Clavis Pharma ASA (Norway) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Clavis Pharma ASA (Norway) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Clavis Pharma ASA (Norway) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Cyclacel Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cyclacel Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cyclacel Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Myeloid Leukemia (AML) Therapeutic
Figure Manufacturing Process Analysis of Acute Myeloid Leukemia (AML) Therapeutic
Figure Acute Myeloid Leukemia (AML) Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Acute Myeloid Leukemia (AML) Therapeutic Major Manufacturers in 2015
Table Major Buyers of Acute Myeloid Leukemia (AML) Therapeutic
Table Distributors/Traders List
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Production and Growth Rate Forecast (2016-2021)
Figure Global Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production Forecast by Regions (2016-2021)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Forecast by Regions (2016-2021)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Production Forecast by Type (2016-2021)
Table Global Acute Myeloid Leukemia (AML) Therapeutic Consumption Forecast by Application (2016-2021)